Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06562205

PAP Systems External Clinical Studies (ECS)

This is a pre-market study for ongoing product development aiming to explore the usability and performance of the study PAP systems.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

This is an open label, prospective, randomized cross over (or single arm) study for ongoing product development of new accessories for PAP devices. This generic protocol provides a framework methodology for how these ongoing studies will be conducted. This protocol then is used in a number of smaller sub-studies phases, each of which will have their own sub-protocol outlining the exact specifics of the study.

The studies could be run face-to-face or remotely.

Participants who met the inclusion/exclusion criteria will be contacted. Recruitment will be done via emails. Participants will be explained the details of the trial and those who wish to take part will be invited to a selected site for the first study visit.

Visit 1: Participants will provide written informed consent. Participants will be shown the PAP systems and trial them for fit and comfort. Participants may be asked initial questions on their first thoughts on the PAP systems. If the participant and assessor are happy to proceed, the participants will use the loan PAP system for trial.

Visit 2: After trialing the PAP systems, participants will be asked to complete a questionnaire regarding the appeal, comfort, and usability of the PAP system(s). Depending on sub-study protocol, participants will then take the second PAP system home to test.

Visit 3: The participant will return the loan PAP system to the assessor. The participants' questionnaire responses will be reviewed. This concludes the participation in the study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants willing to give written informed consent
  • Participants who ≥ 18 years of age
  • Participants being treated for OSA for ≥ 3 months
  • Participants currently using a suitable PAP system(s)
  • Participants who can trial the PAP systems for up to 7 nights each

Additional criteria for remote studies:

  • Participants currently using PAP device compatible with AirView, or with download capacity from PAP machine from data cards
  • Participants who have access to video call equipment

Exclusion criteria

  • Participants using Bilevel flow generators
  • Participants who are or may be pregnant
  • Participants with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury.
  • Participants believed to be unsuitable for inclusion by the researcher
  • Participants who or whose bed partner has implantable medical devices which may contraindicate against masks with magnetic clips (exclusion criteria for study masks with magnetic clips only)
  • Participants who are currently enrolled in other clinical studies

Treatment and study plan

PAP System A (with Amalfi) then PAP System B (with CLA11)

Device

PAP System A (with Amalfi) for 7 days followed by PAP System B (with CLA11) for 7 days

PAP System B (with CLA11) then PAP System A (with Amalfi)

Device

PAP System B (with CLA11) for 7 days followed by PAP System A (with Amalfi) for 7 days

Primary outcomes

  1. (usability) Comparison of the usability of an investigational component/s of the PAP system to a comparison component/s of the PAP system and/or Criterion Score of 6

    Time frame: 6 weeks

    Hypothesis: The investigational component/s of the PAP system will be equivalent to the comparison component/s of the PAP system and/or Criterion Score of 6

    Subjective usability scores will be collected from participants on each usability item (e.g., comfort, seal, ease of use). Scores will be collected using an 11-point Likert Scale where a score of 10 is considered very favorable, and a score of 0 is very unfavorable

  2. (efficacy) Comparison of the investigational component/s of the PAP system efficacy (AHI) to a comparison component/s of the PAP system and/or clinically relevant data

    Time frame: 6 weeks

    Hypothesis: The investigational component/s of the PAP system will be equivalent to the comparison component/s of the PAP system and/or clinically relevant data

    Objective data stored in the CPAP device will be downloaded wirelessly using a computer program (AirView or ResScan, ResMed). An Apnea hypopnea index (AHI) automatically analyzed by the program will be used. Typically, an AHI <5 demonstrates efficacious treatment.

Study contacts

Contact information is provided by the study sponsor or research team.

Xueling Zhu Manager - Clinical Data and Operations

CONTACT

[email protected]

+61288842367

Sponsors and collaborators

Lead sponsor

ResMed

Industry

Registry information

Official study title

External Evaluation of PAP Systems: Comparison of PAP Flow Generators Machines, Mask Systems and Tubing

Important dates

Study start
2028
Primary completion
2028
Study completion
2028
First posted
Aug 20, 2024
Registry last updated
Apr 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.